🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Suresh Chava

University of Hyderabad

ORCID: 0000-0002-9360-5249
Biochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 12 papers. Top paper: “ASAH1 facilitates TNBC by DUSP5 suppression-driven activation of MAP kinase pathway and represents a therapeutic vulnerability”.

ASAH1 facilitates TNBC by DUSP5 suppression-driven activation of MAP kinase pathway and represents a therapeutic vulnerability

Cell Death and Disease(2024)10.1038/s41419-024-06831-2
N/A
0.329DataRank · unranked
7 citations

Suresh Chava, Siva Chander Chabattula, Yvonne J. K. Edwards, Kamaljeet Singh, Romi Gupta +1 more

Measurement of Natural Killer Cell-Mediated Cytotoxicity and Migration in the Context of Hepatic Tumor Cells

Journal of Visualized Experiments(2020)10.3791/60714
N/A
0DataRank · unranked
12 citations

Suresh Bugide, Romi Gupta, Narendra Wajapeyee, Suresh Chava

Loss of HAT1 expression confers BRAFV600E inhibitor resistance to melanoma cells by activating MAPK signaling via IGF1R

Oncogenesis(2020)10.1038/s41389-020-0228-x
N/A
0DataRank · unranked
28 citations

Keshab R. Parajuli, Suresh Chava, Rudradip Pattanayak, Deborah L. Della Manna, Deepmala Shrestha +5 more

Measurement of Natural Killer Cell-Mediated Cytotoxicity and Migration in the Context of Hepatic Tumor Cells

Journal of Visualized Experiments(2020)10.3791/60714-v
N/A
0DataRank · unranked
3 citations

Suresh Bugide, Romi Gupta, Narendra Wajapeyee, Suresh Chava

Disruptor of telomeric silencing 1-like promotes ovarian cancer tumor growth by stimulating pro-tumorigenic metabolic pathways and blocking apoptosis

Oncogenesis(2021)10.1038/s41389-021-00339-6
N/A
0DataRank · unranked
33 citations

Suresh Bugide, Yvonne J. K. Edwards, Romi Gupta, Suresh Chava

The BRD9/7 Inhibitor TP-472 Blocks Melanoma Tumor Growth by Suppressing ECM-Mediated Oncogenic Signaling and Inducing Apoptosis

Cancers(2021)10.3390/cancers13215516
N/A
0DataRank · unranked
32 citations

Suresh Chava, Kiran Kumar Reddi, Romi Gupta, Lawrence David Mason

Betacellulin promotes tumor development and EGFR mutant lung cancer growth by stimulating the EGFR pathway and suppressing apoptosis

iScience(2022)10.1016/j.isci.2022.104211
N/A
0DataRank · unranked
11 citations

Suresh Bugide, Xuchen Zhang, Romi Gupta, Narendra Wajapeyee, Suresh Chava

Co-targeting of specific epigenetic regulators in combination with CDC7 potently inhibit melanoma growth

iScience(2022)10.1016/j.isci.2022.104752
N/A
0DataRank · unranked
6 citations

Suresh Bugide, Parmanand Malvi, Romi Gupta, Suresh Chava

HOXC6 drives a therapeutically targetable pancreatic cancer growth and metastasis pathway by regulating MSK1 and PPP2R2B

Cell Reports Medicine(2023)10.1016/j.xcrm.2023.101285
N/A
0DataRank · unranked
23 citations

Suresh Chava, Guoping Cai, Kai Hu, Lihua Julie Zhu, Yvonne J. K. Edwards +4 more

ATAD2 is a driver and a therapeutic target in ovarian cancer that functions by upregulating CENPE

Cell Death and Disease(2023)10.1038/s41419-023-05993-9
N/A
0DataRank · unranked
18 citations

Suresh Chava, Chiao‐Wang Sun, Nirupama Singh, Courtney A. Penn, Romi Gupta +1 more

Identification of the Mutational Landscape of Gynecological Malignancies

Journal of Cancer(2020)10.7150/jca.46174
N/A
0DataRank · unranked
19 citations

Romi Gupta, Suresh Chava

Loss of EHMT2 enhances NK cell-driven anti-tumor immunity through TGF-β1 suppression

EMBO Molecular Medicine(2025)10.1038/s44321-025-00357-6
N/A
0DataRank · unranked
2 citations

Suresh Bugide, Parmanand Malvi, Kelly D. DeMarco, Boyang Ma, Chaitanya N. Parikh +6 more